• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Center for Tobacco Products Overview

Center for Tobacco Products vision statement, mission statement, and core values PDF thumb nail.  Click to access.The FDA Center for Tobacco Products (CTP) is responsible for carrying out the Family Smoking Prevention and Tobacco Control Act, which Congress passed in 2009. This law – commonly called the Tobacco Control Act – gives us broad authority to regulate the manufacturing, distribution, and marketing of tobacco products. 

--- See a poster of our vision statement, mission statement, and core values (PDF)

 

The Importance of the Tobacco Control Act

Despite major progress over the past half-century, tobacco use continues to be the leading cause of preventable death and disease in the United States.

  •  Nearly 9 out of 10 adult daily smokers began by age 18, the minimum legal age to purchase tobacco products.
  • An estimated 42.1 million Americans – about one in five adults – currently smoke cigarettes.
  • Each year, at least 480,000 people in the U.S. die prematurely from diseases caused by smoking or secondhand smoke exposure.

The statistics around young people are even more sobering.

  • Each day in the United States, more than 3,200 kids under 18 smoke their first cigarette.
  • Each day, more than 700 kids become daily cigarette smokers.
  • Nationwide, nearly one in four high school students currently report using tobacco products.
  • Many of these kids will become addicted before they are old enough to understand the risks and will, on average, die 13 years earlier than non-smokers.

 

This must change.  

 

Improving Public Health

Our goal is to reduce the harm from all regulated tobacco products across the entire population, including:

  • reducing the number of people who start to use  tobacco products
  • encouraging more people to stop using these products
  • reducing the adverse health impact for those who continue to use these products

FDA’s unique position as a regulatory agency allows for a framework of decision-making based on – and within the limits of – both the science and the law. For example, the law gives FDA the authority to adopt science-based product standards, which could require the reduction or elimination of an additive, constituent, or other component if doing so would be appropriate to protect public health.

CTP uses a comprehensive approach as the best way to end the negative health effects of tobacco use. This includes defining policy, issuing regulations, conducting research, educating Americans on regulated tobacco products, and making decisions on whether new products and claims can be marketed—including reviewing and evaluating applications and claims before the products are allowed on the market.

This cohesive, comprehensive approach can help us reach our goals of

  • preventing people from starting to use tobacco products
  • encouraging tobacco users to quit
  • reducing the harm caused by tobacco use

As we work to protect the public’s health, we will use the full power of the law to protect consumers from the dangers of tobacco use. 


Read more about what we are doing in